Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind, Placebo-Controlled, Dose-Response Study of the Safety and Efficacy of Thymosin Beta 4 in the Treatment of Patients With Venous Stasis Ulcers
Conditions
Interventions
Thymosin Beta 4
Placebo
Locations
8
Italy
Chirurgia Vascolare
Bologna, Italy
Università degli Studi di Napoli - Federico II
Naples, Italy
Azienda Ospedaliera di Padova
Padua, Italy
Unità Operativa di Angiologia Azienda Ospedaliera di Padova
Padua, Italy
Istituto Dermopatico dell'Immacolata (IDI)
Rome, Italy
Klinika Chirurgii Naczyń i Angiologii
Lublin, Poland
Start Date
July 1, 2006
Primary Completion Date
January 1, 2009
Completion Date
January 1, 2009
Last Updated
March 30, 2010
NCT01113658
NCT02009501
NCT00852995
NCT00720239
NCT01050023
Lead Sponsor
RegeneRx Biopharmaceuticals, Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions